Skip to Content
77 Mass Ave

Hope for Alzheimer’s

MIT research explains the role of a risky gene.

April 27, 2021
elderly hands with framed flower

One of the most significant known risk factors for developing Alzheimer’s disease is the gene variant called APOE4, which is carried by almost half of all Alzheimer’s patients. A new study from MIT shows that this gene hampers brain cells’ ability to metabolize lipids and respond to stressand that a safe, widely available dietary supplement might be able to help.

Li-Huei Tsai, the director of MIT’s Picower Institute for Learning and Memory, and colleagues including the late Susan Lindquist, who directed MIT’s Whitehead Institute, found that APOE4 significantly disrupted the normal functions of brain cells grown in the lab from human induced pluripotent stem cells. They also showed that treating these cells with extra choline, a nutrient found in foods such as meat, fish, eggs, and broccoli, could reverse many of these effects.

The researchers hope their findings will lead to clinical studies of choline. Previous trials looking at choline’s effects on cognition showed mixed results, but they were not targeted to people with APOE4, who make up about 14% of the population.

“What we would really like to see is whether in the human population, in those APOE4 carriers, if they take choline supplements to a sufficient amount, whether that would delay or give them some protection against developing dementia or Alzheimer’s disease,” Tsai says. 

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.